Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epilepsy, Partial Seizures”

340 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 340 results

Large-scale testing (Phase 3)Study completedNCT01162460
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures

Who this might be right for
Epilepsy
Bial - Portela C S.A. 815
Large-scale testing (Phase 3)Study completedNCT00151879
What this trial is testing

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Who this might be right for
Epilepsies, Partial
UCB Pharma 160
Post-approval studies (Phase 4)Ended earlyNCT01546688
What this trial is testing

Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Limited 41
Large-scale testing (Phase 3)Study completedNCT01142193
What this trial is testing

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Who this might be right for
Epilepsy
Upsher-Smith Laboratories 249
Not applicableEnded earlyNCT04839601
What this trial is testing

RNS System RESPONSE Study

Who this might be right for
EpilepsyPartial SeizureNeurostimulator; Complications+2 more
NeuroPace 9
Large-scale testing (Phase 3)Study completedNCT01463306
What this trial is testing

A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures

Who this might be right for
Epilepsy, Partial SeizuresEpilepsy, Primary Generalized Tonic-Clonic Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 605
Large-scale testing (Phase 3)Study completedNCT00615615
What this trial is testing

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Who this might be right for
Epilepsy
UCB Pharma 216
Large-scale testing (Phase 3)Study completedNCT01389596
What this trial is testing

The Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years

Who this might be right for
Epilepsy, Partial Seizures
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 295
Not applicableStudy completedNCT04252846
What this trial is testing

Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

Who this might be right for
Idiopathic Generalized EpilepsyPartial Onset SeizuresGeneralised Tonic-Clonic Seizures
Eisai Limited 191
Large-scale testing (Phase 3)Study completedNCT03340064
What this trial is testing

Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age

Who this might be right for
Partial Seizures
UCB Japan Co. Ltd. 38
Large-scale testing (Phase 3)Study completedNCT00327717
What this trial is testing

Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures

Who this might be right for
Partial Seizures
Eisai Inc. 240
Large-scale testing (Phase 3)Study completedNCT00848549
What this trial is testing

Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures

Who this might be right for
Epilepsy
Eisai Inc. 295
Large-scale testing (Phase 3)Study completedNCT01832038
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures

Who this might be right for
EpilepsyPartial-onset Seizures
UCB Pharma SA 473
Large-scale testing (Phase 3)Ended earlyNCT00372528
What this trial is testing

An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures

Who this might be right for
Epilepsy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 21
Testing effectiveness (Phase 2)Ended earlyNCT01545518
What this trial is testing

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Who this might be right for
Epilepsy, CryptogenicEpilepsy, PartialSeizure Disorder+2 more
Emory University 20
Large-scale testing (Phase 3)Study completedNCT01364597
What this trial is testing

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Who this might be right for
Epilepsy
UCB Pharma SA 257
Large-scale testing (Phase 3)Study completedNCT02535091
What this trial is testing

Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

Who this might be right for
Partial Epilepsy
SK Life Science, Inc. 1,345
Testing effectiveness (Phase 2)Study completedNCT00800215
What this trial is testing

A Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Intravenous SPM 927

Who this might be right for
Epilepsy
UCB Pharma 60
Post-approval studies (Phase 4)Ended earlyNCT05684978
What this trial is testing

Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus

Who this might be right for
Refractory Status Epilepticus
Wayne State University 1
Testing effectiveness (Phase 2)Study completedNCT00437281
What this trial is testing

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

Who this might be right for
Epilepsies, Partial
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 65
Load More Results